ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning.
Domain
rometx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$72.0M
Founded
2019
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does ROME Therapeutics use?+
We have not yet detected technologies for ROME Therapeutics.
What industry is ROME Therapeutics in?+
ROME Therapeutics operates in the Biotechnology industry.
Where is ROME Therapeutics based?+
ROME Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026